Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,718 papers from all fields of science
Search
Sign In
Create Free Account
acetylacetoin reductase (NADH)
Known as:
AACR II
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
Ling Li
,
Chao Li
,
+8 authors
G. Zhu
Cancer Research
2016
Corpus ID: 5081440
Hypoxia is a common feature of solid tumors and is associated with aggressiveness and poor patient outcomes. Exosomes, initially…
Expand
Review
2016
Review
2016
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
R. Gutteridge
,
M. Ndiaye
,
Xiaoqi Liu
,
N. Ahmad
Molecular Cancer Therapeutics
2016
Corpus ID: 8568767
Polo-like kinase 1 (Plk1) overexpression has been shown to occur in a wide range of tumors, prompting research and development of…
Expand
Highly Cited
2016
Highly Cited
2016
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
H. Lemos
,
Eslam Mohamed
,
+5 authors
A. Mellor
Cancer Research
2016
Corpus ID: 20263017
Cytosolic DNA sensing is an important process during the innate immune response that activates the stimulator of interferon genes…
Expand
Highly Cited
2016
Highly Cited
2016
T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
Y. Kong
,
Liuluan Zhu
,
+7 authors
Hong Zheng
Clinical Cancer Research
2016
Corpus ID: 13002816
Purpose: T-cell immunoglobulin and immunoreceptor tyrosine–based inhibitory motif (ITIM) domain (TIGIT) is a recently identified…
Expand
Highly Cited
2016
Highly Cited
2016
Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
E. Ardini
,
M. Menichincheri
,
+25 authors
A. Galvani
Molecular Cancer Therapeutics
2016
Corpus ID: 23016602
Activated ALK and ROS1 tyrosine kinases, resulting from chromosomal rearrangements, occur in a subset of non–small cell lung…
Expand
Highly Cited
2016
Highly Cited
2016
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.
Yizhou Jiang
,
Yirong Liu
,
+4 authors
Z. Shao
Cancer Research
2016
Corpus ID: 1859358
While recognized as a generally aggressive disease, triple-negative breast cancer (TNBC) is highly diverse in different patients…
Expand
Highly Cited
2016
Highly Cited
2016
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
D. Pietrasz
,
N. Pécuchet
,
+9 authors
J. Bachet
Clinical Cancer Research
2016
Corpus ID: 207566663
Purpose: Despite recent therapeutic advances, prognosis of patients with pancreatic adenocarcinoma remains poor. Analyses from…
Expand
Highly Cited
2016
Highly Cited
2016
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
S. El Messaoudi
,
F. Mouliere
,
+12 authors
A. Thierry
Clinical Cancer Research
2016
Corpus ID: 23380783
Purpose: Circulating cell-free DNA (ccfDNA) is a valuable source of tumor material obtained from a simple blood sampling that…
Expand
Highly Cited
2016
Highly Cited
2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
Andrew Stiff
,
P. Trikha
,
+21 authors
W. Carson
Cancer Research
2016
Corpus ID: 207600677
Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of immature myeloid cells that expand in tumor-bearing hosts in…
Expand
Review
2014
Review
2014
Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
Shipra Das
,
A. Krainer
Molecular Cancer Research
2014
Corpus ID: 7965794
Serine/Arginine Splicing Factor 1 (SRSF1) is the archetype member of the SR protein family of splicing regulators. Since its…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE